公司資料
Ligand Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- LGND
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
302.74 USD (-3.08%)
收盤價
最後更新: 2026年10月1日
4.66B USD
市值
股價為何變動
截至 2026年10月1日，LGND 下跌 3.08%，收於 $302.74。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Ligand Pharmaceuticals is a royalty and technology-enabled biopharma company that monetizes its platform through partnered programs, royalties, and biopharma investments.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Ligand sits in specialty biopharma and royalty-driven healthcare.
商業模式特徵
The business relies on royalties, milestones, and platform economics rather than a single large commercial franchise.
生技產業定位
Ligand is a unique biotech finance-and-royalty hybrid whose stock often tracks deal flow and royalty visibility.
未來催化劑
- Ligand's catalysts are royalty income, portfolio monetization, and capital-allocation updates that show how the company keeps converting assets into cash flow. The story is more about financial engineering than a single drug event.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。